SCI Pharmtech Statistics

Total Valuation

SCI Pharmtech has a market cap or net worth of TWD 9.36 billion. The enterprise value is 9.66 billion.

Market Cap	9.36B
Enterprise Value	9.66B

Important Dates

The last earnings date was Tuesday, March 18, 2025.

Earnings Date	Mar 18, 2025
Ex-Dividend Date	n/a

Share Statistics

SCI Pharmtech has 119.51 million shares outstanding. The number of shares has increased by 9.44% in one year.

Current Share Class	n/a
Shares Outstanding	119.51M
Shares Change (YoY)	+9.44%
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	6.57%
Owned by Institutions (%)	0.52%
Float	68.68M

Valuation Ratios

The trailing PE ratio is 17.56 and the forward PE ratio is 51.18.

PE Ratio	17.56
Forward PE	51.18
PS Ratio	6.14
PB Ratio	1.71
P/TBV Ratio	1.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.64, with an EV/FCF ratio of -112.11.

EV / Earnings	18.06
EV / Sales	6.34
EV / EBITDA	23.64
EV / EBIT	55.31
EV / FCF	-112.11

Financial Position

The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.18.

Current Ratio	1.64
Quick Ratio	0.97
Debt / Equity	0.18
Debt / EBITDA	2.29
Debt / FCF	-11.50
Interest Coverage	35.79

Financial Efficiency

Return on equity (ROE) is 10.11% and return on invested capital (ROIC) is 1.97%.

Return on Equity (ROE)	10.11%
Return on Assets (ROA)	1.78%
Return on Invested Capital (ROIC)	1.97%
Return on Capital Employed (ROCE)	3.21%
Revenue Per Employee	6.38M
Profits Per Employee	2.24M
Employee Count	239
Asset Turnover	0.22
Inventory Turnover	1.94

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.76% in the last 52 weeks. The beta is -0.09, so SCI Pharmtech's price volatility has been lower than the market average.

Beta (5Y)	-0.09
52-Week Price Change	-11.76%
50-Day Moving Average	84.66
200-Day Moving Average	89.36
Relative Strength Index (RSI)	18.99
Average Volume (20 Days)	151,851

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SCI Pharmtech had revenue of TWD 1.52 billion and earned 534.68 million in profits. Earnings per share was 4.46.

Revenue	1.52B
Gross Profit	410.67M
Operating Income	198.29M
Pretax Income	646.86M
Net Income	534.68M
EBITDA	429.73M
EBIT	198.29M
Earnings Per Share (EPS)	4.46

Full Income Statement

Balance Sheet

The company has 692.76 million in cash and 990.39 million in debt, giving a net cash position of -297.63 million or -2.49 per share.

Cash & Cash Equivalents	692.76M
Total Debt	990.39M
Net Cash	-297.63M
Net Cash Per Share	-2.49
Equity (Book Value)	5.48B
Book Value Per Share	45.83
Working Capital	646.01M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 860.52 million and capital expenditures -946.64 million, giving a free cash flow of -86.12 million.

Operating Cash Flow	860.52M
Capital Expenditures	-946.64M
Free Cash Flow	-86.12M
FCF Per Share	-0.72

Full Cash Flow Statement

Margins

Gross margin is 26.95%, with operating and profit margins of 13.01% and 35.09%.

Gross Margin	26.95%
Operating Margin	13.01%
Pretax Margin	42.45%
Profit Margin	35.09%
EBITDA Margin	28.20%
EBIT Margin	13.01%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 1.92%.

Dividend Per Share	1.50
Dividend Yield	1.92%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	27.94%
Buyback Yield	-9.44%
Shareholder Yield	-7.51%
Earnings Yield	5.71%
FCF Yield	-0.92%

Dividend Details

Stock Splits

The last stock split was on July 27, 2023. It was a forward split with a ratio of 1.125.

Last Split Date	Jul 27, 2023
Split Type	Forward
Split Ratio	1.125

Scores

SCI Pharmtech has an Altman Z-Score of 4.59.

Altman Z-Score	4.59
Piotroski F-Score	n/a